# Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer

> **NCT03113019** · EARLY_PHASE1 · UNKNOWN · sponsor: **Research Institute of Fundamental and Clinical Immunology** · enrollment: 26 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Immunotherapy based on dendritic cells

## Key facts

- **NCT ID:** NCT03113019
- **Lead sponsor:** Research Institute of Fundamental and Clinical Immunology
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02-11
- **Primary completion:** 2017-02-11
- **Final completion:** 2017-09-11
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113019, "Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03113019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*